It is highly important and challenging to develop donor-acceptor-donor structured small-molecule second near-infrared window (NIR-II) dyes with excellent properties such as water-solubility and chem/photostability. Here, we discovery an electron acceptor, 6,7-di(thiophen-2-yl)-[1,2,5]thiadiazolo[3,4-g]quinoxaline (TQT) with highest stability in alkaline conditions, compared with conventional NIR-II building block benzobisthiadiazole (BBT) and 6,7-diphenyl-[1,2,5] thiadiazolo[3,4-g]quinoxaline (PTQ). The sulfonated hydrophilic dye, FT-TQT, is further synthesized with 2.13-fold increased quantum yield than its counterpart FT-BBT with BBT as acceptor. FT-TQT complexed with FBS is also prepared and displays a 16-fold increase in fluorescence intensity compared to FT-TQT alone. It demonstrates real-time cerebral and tumor vessel imaging capability with µm-scale resolution. Dynamic monitoring of tumor vascular disruption after drug treatment is achieved by NIR-II fluorescent imaging. Overall, TQT is an efficient electron acceptor for designing innovative NIR-II dyes. The acceptor engineering strategy provides a promising approach to design next generation of NIR-II fluorophores which open new biomedical applications.
Retinal vessel segmentation is of great significance for assisting doctors in diagnosis of ophthalmological diseases such as diabetic retinopathy, macular degeneration and glaucoma. This article proposes a new retinal vessel segmentation algorithm using generative adversarial learning with a large receptive field. A generative network maps an input retinal fundus image to a realistic vessel image while a discriminative network differentiates between images drawn from the database and the generative network. Firstly, the proposed generative network combines shallow features with the upsampled deep features to assemble a more precise vessel image. Secondly, the residual module in the proposed generative and discriminative networks can effectively help deep nets easy to optimize. Moreover, the dilated convolutions in the proposed generative network effectively enlarge the receptive field without increasing the amount of computations. A number of experiments are conducted on two publicly available datasets (DRIVE and STARE) achieving the segmentation accuracy rates of 95.63% and 96.84%, and the average areas under the ROC curve of 98.12% and 98.53%. Performance results show that the proposed automatic retinal vessel segmentation algorithm outperforms state‐of‐the‐art algorithms in many validation metrics. The proposed algorithm can not only detect small tiny blood vessels but also capture large‐scale high‐level semantic vessel features.
Class F G protein-coupled receptors are characterized by a large
extracellular domain (ECD) in addition to the common transmembrane
domain (TMD) with seven α-helixes. For smoothened receptor (SMO),
structural studies revealed dissected ECD and TMD, and their integrated
assemblies. However, distinct assemblies were reported under different
circumstances. Using an unbiased approach based on four series of
cross-conjugated bitopic ligands, we explore the relationship between
the active status and receptor assembly. Different activity dependency
on the linker length for these bitopic ligands corroborates the various
occurrences of SMO assembly. These results reveal a rigid “near”
assembly for active SMO, which is in contrast to previous results.
Conversely, inactive SMO adopts a free ECD, which would be remotely
captured at “far” assembly by cholesterol. Altogether,
we propose a mechanism of cholesterol flow-caused SMO activation involving
an erection of ECD from far to near assembly.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.